Inhibition of Telomerase Activity by Fungus Metabolites, CRM646-A and Thielavin B.
-
- TOGASHI Ken-ichi
- Antibiotics Laboratory, RIKEN Present address: Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo
-
- KO Hack-Ryong
- Antibiotics Laboratory, RIKEN Cellular Response Modifier Research Unit, Korea Research Institute of Bioscience and Biotechnology
-
- AHN Jong-Seog
- Cellular Response Modifier Research Unit, Korea Research Institute of Bioscience and Biotechnology
-
- OSADA Hiroyuki
- Antibiotics Laboratory, RIKEN
Search this article
Abstract
We performed a screening program to identify telomerase inhibitors from our drug source obtained from fungus fermentations, and found that two compounds, CRM646-A and thielavin B, inhibited telomerase activity at doses of 3.2 and 32 μM, respectively. These compounds also inhibited the activity of viral reverse transcriptase at almost the same dose levels which inhibited telomerase activity.
Journal
-
- Bioscience, Biotechnology, and Biochemistry
-
Bioscience, Biotechnology, and Biochemistry 65 (3), 651-653, 2001
Japan Society for Bioscience, Biotechnology, and Agrochemistry
- Tweet
Details 詳細情報について
-
- CRID
- 1390001206473784704
-
- NII Article ID
- 110002680317
-
- NII Book ID
- AA10824164
-
- COI
- 1:CAS:528:DC%2BD3MXisFKqu74%3D
-
- ISSN
- 13476947
- 09168451
-
- NDL BIB ID
- 5738054
-
- PubMed
- 11330682
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed